Douglas A. Schuling

Douglas A. Schuling is a declared insider at 2 companies; the most frequent names are Genoptix Inc and Viridian Therapeutics, Inc.\DE. Over a trading history stretching from 28 February 2008 to 6 August 2015, the count stands at 69 filings.

On the market, this insider has only sold: 21 sales, €2.3M in total. Other entries cover 15 share grants and 30 option exercises.

Most recently, on 10 August 2015, the filings show a share grant in Viridian Therapeutics, Inc.\DE. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.